Why is Jagsonpal Pharma falling/rising?

As of 23-Sep, Jagsonpal Pharmaceuticals Ltd is experiencing a price increase, currently at 241.50, reflecting a rise of 2.75 or 1.15%. Today's price summary indicates that the stock has outperformed its sector by 1.5% and has shown a trend reversal after two consecutive days of decline. The stock's performance over the past week is down by 2.78%, but it has gained 2.63% over the last month. Additionally, the stock has demonstrated strong long-term growth, with a remarkable 46.97% increase over the past year and an impressive 1490.91% rise over the last five years. The company has maintained a low debt-to-equity ratio and has reported positive results for the last five consecutive quarters, contributing to its recent upward movement.
In the broader market context, while the Sensex has decreased by 0.34% over the past week, Jagsonpal Pharmaceuticals has shown resilience with a smaller decline. The stock's ability to outperform the benchmark in both the short and long term, alongside rising investor participation indicated by a significant increase in delivery volume, suggests a positive sentiment among investors. This combination of strong financial performance and favorable market conditions has likely contributed to the stock's recent rise.